3,525 Shares in West Pharmaceutical Services Inc. (WST) Purchased by Princeton Global Asset Management LLC

Princeton Global Asset Management LLC bought a new position in shares of West Pharmaceutical Services Inc. (NYSE:WST) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,525 shares of the medical instruments supplier’s stock, valued at approximately $346,000.

Several other institutional investors also recently made changes to their positions in the company. Intermede Investment Partners Ltd grew its holdings in shares of West Pharmaceutical Services by 5.3% during the fourth quarter. Intermede Investment Partners Ltd now owns 266,471 shares of the medical instruments supplier’s stock valued at $26,122,000 after buying an additional 13,400 shares in the last quarter. Stifel Financial Corp grew its stake in West Pharmaceutical Services by 14.4% in the fourth quarter. Stifel Financial Corp now owns 23,776 shares of the medical instruments supplier’s stock valued at $2,326,000 after purchasing an additional 2,985 shares in the last quarter. Lord Abbett & CO. LLC purchased a new position in West Pharmaceutical Services in the fourth quarter valued at about $12,989,000. Mackenzie Financial Corp purchased a new position in West Pharmaceutical Services in the third quarter valued at about $275,000. Finally, Marshall Wace LLP grew its stake in West Pharmaceutical Services by 614.6% in the third quarter. Marshall Wace LLP now owns 99,369 shares of the medical instruments supplier’s stock valued at $12,269,000 after purchasing an additional 85,464 shares in the last quarter. 94.39% of the stock is currently owned by institutional investors.

Shares of WST traded down $0.12 during trading hours on Friday, hitting $111.52. 379,805 shares of the company were exchanged, compared to its average volume of 368,453. The company has a market cap of $8.22 billion, a PE ratio of 39.69, a price-to-earnings-growth ratio of 3.54 and a beta of 1.25. West Pharmaceutical Services Inc. has a 52 week low of $84.91 and a 52 week high of $125.09. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.40 and a current ratio of 3.15.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, February 14th. The medical instruments supplier reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.01. The company had revenue of $422.50 million during the quarter, compared to the consensus estimate of $432.38 million. West Pharmaceutical Services had a return on equity of 15.89% and a net margin of 12.05%. The firm’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.64 EPS. On average, research analysts predict that West Pharmaceutical Services Inc. will post 2.85 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Wednesday, April 17th will be given a dividend of $0.15 per share. The ex-dividend date is Tuesday, April 16th. This represents a $0.60 annualized dividend and a dividend yield of 0.54%. West Pharmaceutical Services’s dividend payout ratio is presently 21.35%.

Separately, Zacks Investment Research upgraded West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Saturday, January 12th.

ILLEGAL ACTIVITY WARNING: “3,525 Shares in West Pharmaceutical Services Inc. (WST) Purchased by Princeton Global Asset Management LLC” was first reported by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/princeton-global-asset-management-llc-invests-346000-in-west-pharmaceutical-services-inc-wst-stock.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Story: Net Income

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.